Yarrow Bioscience, Inc. Form SCHEDULE 13D/A — Nov 20, 2026
AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management LLC and Len Blavatnik filed Amendment No. 2 to their Schedule 13D on Yarrow Bioscience, Inc., reporting beneficial ownership of 178,179 shares of common stock, or approximately 1.16% of the class. The amendment states that on November 13, 2026, the Reporting Persons ceased to be beneficial owners of more than five percent of Yarrow Bioscience's outstanding common stock, implying prior sales or disposition of their position. The holdings consist of 22,331 shares plus warrants to purchase 155,848 shares, held directly by AI Biotechnology, with each entity and Mr.
Key figures
- Shares Outstanding
- 0
- Warrant shares
- 155848
- Amendment number
- 2
- Date ceased 5pct
- 2026-11-13
- Percent of class
- 1.16%
- Shares owned directly
- 22331
- Shares beneficially owned
- 178179
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.